Joshua Silverman

Joshua Silverman

Chief Executive Officer at PHARMACYTE BIOTECH, INC.

Net worth: 237 076 $ as of 30/03/2024

53 year
Health Technology
Finance
Consumer Services

Profile

Joshua Nathaniel Silverman founded Iroquois Capital LP in 2002, where he is working as Chief Executive Officer from 2002, Iroquois Capital Management LLC in 2003, where he worked as Co-Chief Investment Officer & Managing Member from 2003 to 2016, and Parkfield Funding LLC in 2016, where he is working as Managing Member from 2016.
Mr. Silverman also currently works at PharmaCyte Biotech, Inc., as Chairman, President & Chief Executive Officer from 2022, Neurotrope, Inc., as Chairman from 2016, Synaptogenix, Inc., as Independent Chairman from 2016, Petros Pharmaceuticals, Inc., as Vice Chairman from 2020, AYRO, Inc., as Executive Chairman, Chief Financial Officer & CAO from 2024, MyMD Pharmaceuticals, Inc., as Chairman, Femasys, Inc., as Independent Director from 2023, Crellin Capital LLC, as Director, and Taplmmune, Inc., as Director.
Mr. Silverman also formerly worked at DropCar, Inc., as Chairman, MIRA Pharmaceuticals, Inc., as Chairman, Alanco Technologies, Inc., as Director in 2016, National Holdings Corp., as Independent Director from 2014 to 2016, WPCS International, Inc., as Director, Marker Therapeutics, Inc., as Independent Director from 2016 to 2018, Akers Biosciences, Inc., as Lead Independent Director from 2018 to 2020, MGT Capital Investments, Inc., as Independent Director from 2014 to 2016, Atrinsic, Inc., as Director, Joele Frank, Wilkinson Brimmer Katcher, as Director, JNS Holdings Corp., as Director, Protagenic Therapeutics, Inc., as Independent Non-Executive Director from 2016 to 2022, and Vertical Ventures LLC, as Co-Chief Investment Officer from 2000 to 2003.
Mr. Silverman received his undergraduate degree in 1992 from Lehigh University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
19/03/2024 50,000 ( 0.59% ) 118 500 $ 30/03/2024
26/10/2023 49,584 ( 1.01% ) 82 805 $ 30/03/2024
25/03/2024 11,238 ( 0.51% ) 16 632 $ 30/03/2024
28/03/2024 5,000 ( 0.23% ) 11 950 $ 30/03/2024
07/04/2024 38,238 ( 0.19% ) 7 189 $ 30/03/2024

Joshua Silverman active positions

CompaniesPositionStart
NEUROTROPE, INC. Chairman 03/08/2016
AYRO, INC. Director of Finance/CFO 29/02/2024
PETROS PHARMACEUTICALS Director/Board Member 31/12/2019
SYNAPTOGENIX, INC. Chairman 03/08/2016
MYMD PHARMACEUTICALS, INC. Chairman -
PHARMACYTE BIOTECH, INC. Chief Executive Officer 05/10/2022
FEMASYS INC. Director/Board Member 20/11/2023
Founder 31/07/2016
Taplmmune, Inc. Director/Board Member -
░░░░░░░ ░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
All active positions of Joshua Silverman

Former positions of Joshua Silverman

CompaniesPositionEnd
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Joshua Silverman's experience

Training of Joshua Silverman

Lehigh University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joshua Silverman's experience

Connections

99

1st degree connections

26

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies11
MARKER THERAPEUTICS, INC.

Health Technology

FEMASYS INC.

Electronic Technology

MGT CAPITAL INVESTMENTS, INC.

Technology Services

PHARMACYTE BIOTECH, INC.

Health Technology

JNS HOLDINGS CORPORATION

Industrial Services

SYNAPTOGENIX, INC.

Health Technology

PROTAGENIC THERAPEUTICS, INC.

Health Technology

PETROS PHARMACEUTICALS

Health Technology

AYRO, INC.

Producer Manufacturing

MYMD PHARMACEUTICALS, INC.

Health Technology

MIRA PHARMACEUTICALS, INC.

Health Technology

Private companies14

Industrial Services

Finance

Consumer Services

Health Technology

Finance

Health Technology

Finance

Commercial Services

Finance

Commercial Services

Finance

Finance

Consumer Services

Taplmmune, Inc.

See company connections
  1. Stock Market
  2. Insiders
  3. Joshua Silverman